On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

The recent decision by the U.S. Food and Drug Administration (FDA) to authorize the marketing of 20 ZYN nicotine pouch ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

After "an extensive scientific review," the FDA said, the products were found to pose lower risks of cancer and other serious ...

The agency highlighted several critical findings: Reduced harm: ZYN nicotine pouches contain significantly lower levels of harmful constituents compared to cigarettes and most smokeless tobacco ...

Facing falling tobacco sales and a waning user base, tobacco manufacturers are having an identity crisis, now shifting their ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.

The authorized products pose a lower risk of cancer and other serious health conditions than cigarettes and most smokeless tobacco ... for Tobacco-Free Kids, adding that the nicotine pouch ...